BACKGROUND: We previously showed that the infusion of tumor necrosis factor alpha (TNF-alpha) induces hypertension and vascular dysfunction in late pregnant but not virgin rats. In the present study, we tested the hypothesis that levels of ovarian hormones to mimic pregnancy are required for TNF-alpha-induced changes in vascular function and blood pressure in rats. METHODS: Twenty-one-day-release pellets containing 17beta-estradiol, progesterone, or both were implanted in ovariectomized (OVX) rats. Sham OVX rats were used as controls. Twelve days after implantation, TNF-alpha or vehicle was infused via osmotic minipumps (days 12 to 17). On day 18, mean arterial pressure was measured, and animals were sacrificed to assess vascular function. RESULTS: Average estrogen and progesterone levels across all groups were 106 +/- 6 pg/mL and 88 +/- 5 ng/mL, respectively. The level of TNF-alpha was 41 +/- 7 pg/mL compared with OVX rats infused with vehicle (4 +/- 1 pg/mL). The results show that TNF-alpha did not cause elevated mean arterial pressure in OVX rats with increased estrogen, progesterone, or both. Vascular responses to the endothelium-dependent and independent agonists, acetylcholine and sodium nitroprusside, were also unchanged. Phenylephrine-induced contraction was moderately but significantly increased at the highest concentrations (10(-4) M) only in TNF-alpha-infused rats. CONCLUSIONS: These data suggest that increased ovarian hormones to the levels observed during pregnancy are not sufficient to promote TNF-alpha-induced increases in blood pressure or vascular dysfunction.
BACKGROUND: We previously showed that the infusion of tumor necrosis factor alpha (TNF-alpha) induces hypertension and vascular dysfunction in late pregnant but not virgin rats. In the present study, we tested the hypothesis that levels of ovarian hormones to mimic pregnancy are required for TNF-alpha-induced changes in vascular function and blood pressure in rats. METHODS: Twenty-one-day-release pellets containing 17beta-estradiol, progesterone, or both were implanted in ovariectomized (OVX) rats. Sham OVX rats were used as controls. Twelve days after implantation, TNF-alpha or vehicle was infused via osmotic minipumps (days 12 to 17). On day 18, mean arterial pressure was measured, and animals were sacrificed to assess vascular function. RESULTS: Average estrogen and progesterone levels across all groups were 106 +/- 6 pg/mL and 88 +/- 5 ng/mL, respectively. The level of TNF-alpha was 41 +/- 7 pg/mL compared with OVX rats infused with vehicle (4 +/- 1 pg/mL). The results show that TNF-alpha did not cause elevated mean arterial pressure in OVX rats with increased estrogen, progesterone, or both. Vascular responses to the endothelium-dependent and independent agonists, acetylcholine and sodium nitroprusside, were also unchanged. Phenylephrine-induced contraction was moderately but significantly increased at the highest concentrations (10(-4) M) only in TNF-alpha-infused rats. CONCLUSIONS: These data suggest that increased ovarian hormones to the levels observed during pregnancy are not sufficient to promote TNF-alpha-induced increases in blood pressure or vascular dysfunction.
Authors: J J Peschon; D S Torrance; K L Stocking; M B Glaccum; C Otten; C R Willis; K Charrier; P J Morrissey; C B Ware; K M Mohler Journal: J Immunol Date: 1998-01-15 Impact factor: 5.422
Authors: Kiran B Tam Tam; Babbette Lamarca; Marietta Arany; Kathy Cockrell; Lillian Fournier; Sydney Murphy; James N Martin; Joey P Granger Journal: Am J Hypertens Date: 2010-08-19 Impact factor: 2.689
Authors: Marc R Parrish; Michael J Ryan; Porter Glover; Justin Brewer; Lillian Ray; Ralf Dechend; James N Martin; Babbette B Lamarca Journal: Gend Med Date: 2011-05-20
Authors: Licy L Yanes; Damian G Romero; Mohaddetheh Moulana; Roberta Lima; Deborah D Davis; Huimin Zhang; Rachel Lockhart; Lorraine C Racusen; Jane F Reckelhoff Journal: Gend Med Date: 2011-04
Authors: Jason P Bridges; Jeffrey S Gilbert; Drew Colson; Sara A Gilbert; Matthew P Dukes; Michael J Ryan; Joey P Granger Journal: Am J Hypertens Date: 2009-03-05 Impact factor: 2.689
Authors: Zhekang Ying; Jussara M do Carmo; Lusha Xiang; Alexandre A da Silva; Minjie Chen; Michael J Ryan; Michael Ostrowski; Sanjay Rajagopalan; John E Hall Journal: Circ Res Date: 2013-07-01 Impact factor: 17.367
Authors: Panita Maturavongsadit; Roopali Shrivastava; Craig Sykes; Mackenzie L Cottrell; Stephanie A Montgomery; Angela D M Kashuba; S Rahima Benhabbour Journal: Int J Pharm Date: 2021-07-01 Impact factor: 6.510